|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-2-2
|
|
pubmed:abstractText |
This study evaluated the impact on quality of life (QoL) of an algorithm guiding the responses of continuous subcutaneous insulin infusion (CSII)-treated type 1 diabetes (T1D) patients using real-time (RT)-continuous glucose monitoring (CGM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1557-8593
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
105-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21284476-Adolescent,
pubmed-meshheading:21284476-Adult,
pubmed-meshheading:21284476-Aged,
pubmed-meshheading:21284476-Algorithms,
pubmed-meshheading:21284476-Australia,
pubmed-meshheading:21284476-Blood Glucose,
pubmed-meshheading:21284476-Decision Support Techniques,
pubmed-meshheading:21284476-Diabetes Mellitus, Type 1,
pubmed-meshheading:21284476-Female,
pubmed-meshheading:21284476-Follow-Up Studies,
pubmed-meshheading:21284476-Hemoglobin A, Glycosylated,
pubmed-meshheading:21284476-Humans,
pubmed-meshheading:21284476-Hypoglycemic Agents,
pubmed-meshheading:21284476-Insulin,
pubmed-meshheading:21284476-Insulin Infusion Systems,
pubmed-meshheading:21284476-Male,
pubmed-meshheading:21284476-Middle Aged,
pubmed-meshheading:21284476-Monitoring, Physiologic,
pubmed-meshheading:21284476-Patient Dropouts,
pubmed-meshheading:21284476-Patient Education as Topic,
pubmed-meshheading:21284476-Quality of Life,
pubmed-meshheading:21284476-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.
|
|
pubmed:affiliation |
University of Melbourne Department of Medicine, St. Vincent's Hospital, Fitzroy, Australia.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
